Tesamorelin

Description

Tesamorelin is supplied as a lyophilized modified GHRH analog for controlled laboratory investigation. Tesamorelin is used in preclinical research models studying growth-hormone release dynamics, pituitary signaling, lipid-metabolism markers, visceral-adiposity research endpoints, and endocrine response pathways.

Research positioning

This product is intended for qualified laboratory research workflows only. It is not supplied for personal use, weight-management use, clinical use, compounding, human administration, veterinary administration, diagnosis, treatment, mitigation, or prevention of disease.

Product specifications

• Compound: Tesamorelin
• Format: Lyophilized powder
• Testing: HPLC purity verification
• Storage: Refrigerated storage recommended at 2-8°C
• Intended use: Laboratory research only

Documentation

Batch documentation is available on request while the downloadable COA library is being finalized. Documentation may include batch reference, purity verification, testing method, release status, and storage guidance.

Research-use notice

For research use only. Not for human or veterinary use. Buyer is responsible for compliance with local laws, institutional rules, and applicable research ethics requirements.